No association between a genetic variant of the p22PHOX component of NADPH oxidase C242T and ulcerative colitis

Hepato-Gastroenterology

Volumn 55, Issue 86-87, 2008, Pages 1573-1577

  Tahara, Tomomitsu ^a,d   Arisawa, Tomiyasu ^c   Fujita, Hiroshi ^a   Kamiya, Yoshio ^a   Nagasaka, Mitsuo ^a   Iwata, Masami ^a   Wang, Fangyu ^a   Shibata, Tomoyuki ^a   Nakamura, Masakatsu ^a   Yoshioka, Daisuke ^a   Okubo, Masaaki ^a   Takahama, Kazuya ^a   Watanabe, Makoto ^a   Nakano, Hiroshi ^b   Hirata, Ichiro ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

^d NONE   (Japan)

Author keywords

p22PHOX; Polymorphism; Ulcerative colitis

Indexed keywords

CYTOSINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STEROID; TYROSINE;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADULT; AGED; COLITIS, ULCERATIVE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NADPH OXIDASE; POLYMORPHISM, GENETIC;

EID: 57049135800     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Head KA, Jurenka JS: Inflammatory bowel disease part I: Ulcerative colitis-pathophysiology and conventional and alternative treatment options. Altern Med Rev 2003; 8:247-283.
2. Blumberg RS, Strober W: Prospects for research in inflammatory bowel diseases. JAMA 2001; 285:643-647.
3. Mahida YR, Ceska M, Effenberger F, Kurlak L, Lindley I, Hawkey CJ: Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative cotitis. Clin Sci (Lond) 1992; 82:273-275.
4. MacDonald TT, Murch SH: Aetiology and pathogenesis of chronic inflammatory bowel disease. Baillieres Clin Gastroenterol 1994; 8:1-34.
5. Lakatos PL, Fischer S, Lakatos L, Gal I, Papp J: Current concept on the pathogenesis of infl ammatory boweldisease-crosstalk between genetic and microbial factors: Pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll"? World J Gastroenterol 2006; 12:1829-1841.
6. Lakatos L, Lakatos PL: Etiopathogenesis of inflammatory bowel diseases. Orv Hetil 2003; 144:1853-1860.
7. Hugot JP: Inflammatory bowel disease: causes and consequences. Best Pract Res Clin Gastroenteral 2004; 18:447-449.
8. Hugot JP, Thomas G: Genome-wide scanning in inflammatory bowel diseases. Dig Dis 1998; 6:364-369.
9. Annese V, Valvano MR, Palmieri O, Latiano A, Bossa F, Andriulli A: Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. World J Gastroenterol 2006; 12:3636-3644.
10. Jiang Y, Xia B, Jiang L, Ly M, Guo Q, Chen M, Li J, Xia HH, Wong BC: Association of CTLA-4 gene microsatellite polymorphism with ulcerative calitis in Chinese patients. Inflamm Bowel Dis 2006; 12:369-373.
11. Castro-Santos P, Suarez A, Lopez-Rivas L, Mozo L, Gutierrez C: TINFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency. Am J Gastroepterol 2006; 101:1039-1047.
12. Pierik M, Joossens S, Van Steen K, Van Schuerbeek N, Vlietinck R, Rutgeerts P, Vermeire S: Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 2006; 12:1-8.
13. Takagawa T, Tamura K, Takeda N, Tomita T, Ohda Y, Fukunaga K, Hida N, Ohnishi K, Hori K, Kosaka T, Fukuda Y, Ikeuchi H, Yamamura T, Miwa H, Matsumoto T: Association between IL-18 gene promoter polymorphisms and inflammatory bowel disease in a Japanese population. Inflamm Bowel Dis 2005; 11:1038-1043.
14. Torok HP, Glas J, Tonenchi L, Mussack T, Folwaczny C: Polymorphisms of the lipopolysaccharide-sigualing oumplex in inflammatory bowel disease: association of a mutation in tbe Toll-like receptor 4 gene with ulcerative colitis. Clin Immunol 2004; 112:85-91.
15. Obana N, Takahashi S, Kinouchi Y, Negoro K, Takagi S, Hiwatashi N, Shimosegawa T: Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand J Gastroexiterol 2002; 37:699-704.
16. Pravda J: Radical induction theory of ulcerative colitis. World J Gastroenterol 2005; 11:2371-2384.
17. Burdon RH: Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995; 18:775-794.
18. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, Weissman GS, Katz S, Floyd RA, McKinley MJ, Fisher SE, Mullin GE: Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996; 41:2078-2086.
19. Babior BM: NADPH oxidase: an update. Blood 1999; 93:1464-1476.
20. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM: Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22PHOX gene on vascular superoxide production in atherosclerosis. Circulation 2000; 102:1744-1747.
21. Takeya R, Ueno N, Kami K, Kohjima M, Izaki T, Nunoi H, Sumitomo H: Novel human homologues of p47phox and p67pbox participate in activation of superoxide-producing NADPH oxdases. J Biol Chem 2003; 278:24234-24246.
22. Podolsky DK: Inflammatory bowel disease 2. N Engl J Med 1991; 325:928-937.
23. Langholz E, Munkholm P, Davidsen M, Binder V: Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994; 107:3-11.
24. Sartor RB: Cytokines in intestinal inflammation; pathophysiological and clinical considerations. Gastroenterology 1994; 106:533-539.
25. Babbs CF: Oxygen radicals in ulcerative colitis. Free Radical Biol Med 1992; 13:169-181.
26. Williams JG, Hughes LE, Hallett MB: Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease. Gut 1990; 31:187-193.
27. Mahida YR, Wu KC, Jewell DP: Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease. Gut 1989; 30:1362-1370.
28. Simmonds NJ, Allen RE, Stevens TRJ, Niall R, Van-Someren M, Blake DR, Rampton DS: Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 1992; 103:186-196.
29. Grisham MB, Gaginella TS, von Ritter C, Tamai H, Be RM, Granger DN: Effects of neutrophil-derived oxidants on intestinal permeability, electrolyte transport, and epithelial cell viability. Inflammation 1900; 14:531-542.
30. Middleton SJ, Shorthouse M, Hunter JO: Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993; 341:465-466.
31. Grisham MB, Yamada T: Neutropthils, nitrogen oxides and inflammatory bowel disease. Ann NY Acad Sci 1992; 664:103-115.
32. Ribbons KA, Zhang XJ, Thompson JH, Greenberg SS, Moore WM, Kornmeier CM, Currie MG, Lerche N, Blanchard J, Clark DA, Miller MJS: Potential role of nitric oxide in a model of chronic colitis in Rhesus Macaques. Gastroenterolou 1995; 108:705-711.
33. Keshavarzian A, Morgan G, Sedghi S, Gordon JM, Doria M: Role of reactive oxygen metabolites in experimental colitis. Gut 1990; 31:786-790.
34. von Ritter C, Grisham MB, Hollwarth M, Inauen W, Granger DN: Neutrophil-derived oxidants mediate formyl-methionyl-leucylphenylalanine-induced increases in mucosal permeability in rats. Gastroenterology 1989; 97:778-780.
35. Niwa Y, Somiya K, Michelson AM, Puget K: Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study. Free Radical Res Commun 1985; 1:137-153.
36. Emerit J, Pelletier S, Likforman J, Pasquier C, Thuillier A: Phase II trial of copper zinc superoxide dismutase (CuZn SOD) in treatment of Crohn's disease. Free Radic. Res. Commun 1991; 12-13:563-569.
37. Miller MJS, Sadowska-Krowicka H, Chotinaruemol S, Kakkis JL, DA Clark: Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 1993; 264:11-16.
38. Gardemann A, Mages P, Katz N, Tillmanns H, Haberbosch W: The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis 1999; 145:315-323.